Regis Resources (ASX: RRL) drops Vault Minerals bid, letting Genesis Minerals’s A$5.6bn offer proceed
Read More Pharma Industry News Biocon Biologics reports positive Phase 3 results for Yesintek, biosimilar to Ustekinumab Biocon Biologics Ltd., a global leader in biosimilar medicines and a subsidiary of India’s pioneering biopharmaceutical giant Biocon… byPallavi MadhirajuMarch 8, 2025